Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 28 | 0 | 0 | 28 |
ATAD5 protein, partial | 8 | 0 | 0 | 8 |
GLS protein | 11 | 0 | 0 | 11 |
Microtubule-associated protein tau | 13 | 0 | 0 | 13 |
Smad3 | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 18 | 0 | 0 | 18 |
thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 1, group I, member 3 | 25 | 0 | 0 | 25 |
progesterone receptor | 20 | 0 | 0 | 20 |
EWS/FLI fusion protein | 11 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 29 | 0 | 0 | 29 |
retinoid X nuclear receptor alpha | 23 | 0 | 0 | 23 |
estrogen-related nuclear receptor alpha | 29 | 0 | 0 | 29 |
estrogen nuclear receptor alpha | 44 | 0 | 0 | 44 |
peroxisome proliferator activated receptor gamma | 21 | 0 | 0 | 21 |
aryl hydrocarbon receptor | 15 | 0 | 0 | 15 |
chromobox protein homolog 1 | 22 | 0 | 0 | 22 |
thyroid hormone receptor beta isoform 2 | 28 | 0 | 0 | 28 |
peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
cytochrome P450 3A4 isoform 1 | 13 | 0 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit pi | 13 | 6 | 2 | 21 |
ATP-binding cassette sub-family C member 3 | 0 | 17 | 0 | 17 |
Multidrug resistance-associated protein 4 | 0 | 17 | 0 | 17 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Voltage-dependent calcium channel gamma-2 subunit | 20 | 0 | 0 | 20 |
Bile salt export pump | 0 | 32 | 0 | 32 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 5 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 2 | 1 | 4 |
Cytochrome P450 1A2 | 0 | 4 | 0 | 5 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 10 | 1 | 12 |
Cytochrome P450 2D6 | 0 | 7 | 0 | 7 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 13 | 6 | 2 | 21 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 13 | 6 | 2 | 21 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
Glutamate receptor 2 | 20 | 0 | 0 | 20 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 13 | 6 | 2 | 21 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 13 | 6 | 2 | 21 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit beta-3 | 13 | 6 | 2 | 21 |
Gamma-aminobutyric acid receptor subunit beta-2 | 13 | 6 | 2 | 21 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
GABA theta subunit | 13 | 6 | 2 | 21 |
Canalicular multispecific organic anion transporter 1 | 0 | 16 | 0 | 16 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 13 | 6 | 2 | 21 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
Luciferase | 12 | 0 | 0 | 12 |
glp-1 receptor, partial | 8 | 0 | 0 | 8 |
hypoxia-inducible factor 1 alpha subunit | 12 | 0 | 0 | 12 |
Fumarate hydratase | 9 | 0 | 0 | 9 |
TDP1 protein | 31 | 0 | 0 | 31 |
GLI family zinc finger 3 | 33 | 0 | 0 | 33 |
AR protein | 36 | 0 | 0 | 36 |
caspase 7, apoptosis-related cysteine protease | 9 | 0 | 0 | 9 |
glucocorticoid receptor [Homo sapiens] | 24 | 0 | 0 | 24 |
farnesoid X nuclear receptor | 14 | 0 | 0 | 14 |
pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
polyprotein | 9 | 0 | 0 | 9 |
67.9K protein | 6 | 0 | 0 | 6 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 22 | 0 | 0 | 22 |
caspase-3 | 9 | 0 | 0 | 9 |
IDH1 | 12 | 0 | 0 | 12 |
euchromatic histone-lysine N-methyltransferase 2 | 30 | 0 | 0 | 30 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 17 | 0 | 0 | 17 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 16 | 0 | 0 | 16 |
nuclear receptor subfamily 1, group I, member 2 | 7 | 0 | 0 | 7 |
Histone H2A.x | 16 | 0 | 0 | 16 |
cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 11 | 0 | 0 | 11 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 11 | 0 | 0 | 11 |
mitogen-activated protein kinase 1 | 12 | 0 | 0 | 12 |
urokinase-type plasminogen activator precursor | 8 | 0 | 0 | 8 |
plasminogen precursor | 8 | 0 | 0 | 8 |
urokinase plasminogen activator surface receptor precursor | 8 | 0 | 0 | 8 |
geminin | 24 | 0 | 0 | 24 |
Vif | 0 | 1 | 0 | 2 |
survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 1 | 0 | 3 |
lamin isoform A-delta10 | 22 | 0 | 0 | 22 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Interferon beta | 21 | 0 | 0 | 21 |
Cellular tumor antigen p53 | 24 | 0 | 0 | 24 |
Integrin beta-3 | 3 | 0 | 0 | 3 |
Integrin alpha-IIb | 3 | 0 | 0 | 3 |
Methionine aminopeptidase | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
ATPase family AAA domain-containing protein 5 | 11 | 0 | 0 | 11 |
Ataxin-2 | 13 | 0 | 0 | 13 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 19 | 0 | 0 | 19 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 5 | 0 | 0 | 5 |
Chain A, Cruzipain | 8 | 0 | 0 | 8 |
Beta-lactamase | 0 | 1 | 0 | 3 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 3 |
DNA polymerase beta | 7 | 0 | 0 | 7 |
DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 13 | 0 | 0 | 13 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 5 | 0 | 5 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 12 | 0 | 2 | 14 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 3 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Metallo-b-lactamase | 0 | 0 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 3 |
Histamine H3 receptor | 0 | 0 | 0 | 3 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 3 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
USP1 protein, partial | 15 | 0 | 0 | 15 |
cytochrome P450 2D6 isoform 1 | 7 | 0 | 0 | 7 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
lethal factor (plasmid) | 4 | 0 | 0 | 4 |
Histamine H1 receptor | 0 | 0 | 2 | 2 |
cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 9 | 0 | 10 |
5-hydroxytryptamine receptor 4 | 0 | 12 | 1 | 13 |
Muscarinic acetylcholine receptor M2 | 0 | 7 | 3 | 14 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 3 | 12 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 2 | 12 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 2 | 11 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 3 | 12 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 11 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 3 | 13 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 3 | 12 |
Alpha-1D adrenergic receptor | 0 | 11 | 1 | 12 |
5-hydroxytryptamine receptor 2C | 0 | 12 | 0 | 12 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 7 | 0 | 0 | 8 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Reverse transcriptase/RNaseH | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor | 0 | 3 | 1 | 4 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 9 | 0 | 0 | 9 |
Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
interleukin 8 | 5 | 0 | 0 | 5 |
acetylcholinesterase | 12 | 0 | 0 | 12 |
thioredoxin reductase | 17 | 0 | 0 | 17 |
phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
SMAD family member 2 | 7 | 0 | 0 | 7 |
SMAD family member 3 | 7 | 0 | 0 | 7 |
thioredoxin glutathione reductase | 7 | 0 | 0 | 7 |
G | 15 | 0 | 0 | 15 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 18 | 0 | 0 | 18 |
arylsulfatase A | 9 | 0 | 0 | 9 |
thyroid stimulating hormone receptor | 17 | 0 | 0 | 17 |
activating transcription factor 6 | 10 | 0 | 0 | 10 |
Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 26 | 0 | 0 | 26 |
M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
HLA class I histocompatibility antigen, B alpha chain | 15 | 0 | 0 | 15 |
Inositol hexakisphosphate kinase 1 | 15 | 0 | 0 | 15 |
Protein-arginine deiminase type-4 | 0 | 9 | 0 | 9 |
cytochrome P450 2C9, partial | 15 | 0 | 0 | 15 |
Potassium channel subfamily K member 3 | 0 | 5 | 0 | 5 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
GALC protein | 3 | 0 | 0 | 3 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 4 | 0 | 6 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Albumin | 0 | 3 | 5 | 9 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Kappa-type opioid receptor | 0 | 4 | 0 | 6 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
PAX8 | 0 | 0 | 0 | 1 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
pregnane X receptor | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
PINK1 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 26 | 0 | 0 | 26 |
cytochrome P450 2D6 | 15 | 0 | 0 | 15 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
Parkin | 2 | 0 | 0 | 2 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
calcineurin A1, putative | 0 | 0 | 1 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
perilipin-5 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 8 | 0 | 0 | 8 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 12 | 0 | 0 | 12 |
protein AF-9 isoform a | 0 | 0 | 0 | 3 |
snurportin-1 | 5 | 0 | 0 | 5 |
melanocortin receptor 4 | 0 | 1 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 7 | 0 | 0 | 7 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hexokinase HKDC1 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 3 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 3 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 5 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 3 | 0 | 3 |
Alpha-synuclein | 3 | 4 | 0 | 7 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Spermine oxidase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Chain A, HADH2 protein | 7 | 0 | 0 | 7 |
Chain B, HADH2 protein | 7 | 0 | 0 | 7 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 4 |
DNA gyrase subunit B | 0 | 2 | 0 | 4 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 3 | 0 | 3 |
DNA gyrase subunit A | 0 | 3 | 0 | 3 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 7 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 9 | 0 | 10 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 14 | 3 | 17 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 7 | 0 | 7 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Insulin receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2B adrenergic receptor | 0 | 10 | 1 | 11 |
Alpha-2C adrenergic receptor | 0 | 12 | 2 | 14 |
D | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 10 | 1 | 11 |
Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
D(1A) dopamine receptor | 0 | 5 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-1D adrenergic receptor | 0 | 5 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 0 | 10 |
5-hydroxytryptamine receptor 1B | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1B adrenergic receptor | 0 | 2 | 1 | 3 |
D(3) dopamine receptor | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 10 | 0 | 10 |
Alpha-1A adrenergic receptor | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Neutral alpha-glucosidase AB | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 2 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Heparanase | 0 | 0 | 1 | 1 |
regulator of G-protein signaling 4 | 9 | 0 | 0 | 9 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Alpha-1A adrenergic receptor | 0 | 0 | 2 | 2 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A2a | 0 | 1 | 1 | 2 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
Nischarin | 0 | 1 | 0 | 1 |
endonuclease IV | 5 | 0 | 0 | 5 |
dopamine D1 receptor | 5 | 0 | 0 | 5 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 8 | 2 | 15 |
Sex hormone-binding globulin | 0 | 0 | 3 | 3 |
Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
Corticosteroid-binding globulin | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 3 | 7 | 0 | 0 | 7 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Androgen receptor | 0 | 7 | 0 | 7 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Thymidine kinase 2 | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 2 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 0 | 0 | 2 |
AAA family ATPase | 0 | 0 | 0 | 2 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 7 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 4 | 7 |
Translocator protein | 0 | 2 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 3 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 2 | 5 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 3 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 3 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
NS5 | 0 | 0 | 1 | 1 |
PPM1D protein | 5 | 0 | 0 | 5 |
Spike glycoprotein | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
Glucose transporter | 0 | 1 | 0 | 1 |
Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 0 | 2 | 2 |
Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
Adenylate cyclase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
Estrogen receptor | 0 | 6 | 1 | 8 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A1 | 0 | 4 | 0 | 4 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
Mu-type opioid receptor | 0 | 5 | 3 | 11 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 3 | 1 | 5 |
Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Pantothenate synthetase | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 4 | 2 | 7 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 3 | 1 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Chain A, DEOXYNUCLEOSIDE KINASE | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Chain E, Fibrin beta chain | 0 | 2 | 0 | 2 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
WRN | 2 | 0 | 0 | 2 |
Mcl-1 | 0 | 1 | 0 | 1 |
MPI protein | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
luciferase | 2 | 0 | 0 | 2 |
pyruvate kinase | 1 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
CDK5 | 0 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 7 | 0 | 0 | 7 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 9 | 0 | 0 | 9 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
phosphoglycerate kinase | 4 | 0 | 0 | 4 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 2 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
Cytochrome P450 3A5 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Beta-lactamase TEM | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Chain A, BETA-SPECTRIN | 0 | 0 | 1 | 1 |
Chain A, Phospholipase C Delta-1 | 0 | 0 | 1 | 1 |
Chain A, Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 1 | 1 |
Inositol-trisphosphate 3-kinase A | 0 | 1 | 0 | 1 |
Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 2 | 2 |
Inositol 1,4,5-trisphosphate receptor type 2 | 0 | 1 | 0 | 1 |
Inositol 1,4,5-trisphosphate receptor type 3 | 0 | 1 | 1 | 2 |
Inositol polyphosphate-5-phosphatase A | 0 | 1 | 0 | 1 |
Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
Caspase-1 | 0 | 2 | 0 | 2 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
Vpr | 2 | 0 | 0 | 2 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Albumin | 0 | 1 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
Cruzipain | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 2 | 0 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 2 | 0 | 2 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 2 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Chain A, Thymidylate Synthase | 0 | 1 | 0 | 1 |
Chain A, Thymidylate Synthase | 0 | 1 | 0 | 1 |
Chain A, Thymidylate Synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 2 | 0 | 2 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Serine hydroxymethyltransferase, cytosolic | 0 | 1 | 1 | 2 |
Reduced folate transporter | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Proton-coupled folate transporter | 0 | 2 | 0 | 3 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Endolysin | 0 | 0 | 1 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
N | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
Riboflavin-binding protein | 0 | 1 | 1 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 2 |
DNA-directed RNA polymerase subunit alpha | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit omega | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta' | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Acidic phospholipase A2 2 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 4 |
Insulin-degrading enzyme | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Sialidase | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 0 | 2 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Chain A, Uracil-DNA Glycosylase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |